Complex multilocus effects of catechol-O-methyltransferase haplotypes predict pain and pain interference 6 weeks after motor vehicle collision

NeuroMolecular Medicine

Volumn 16, Issue 1, 2014, Pages 83-93

  Bortsov, Andrey V ^a,b   Diatchenko, Luda ^a   McLean, Samuel A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Catechol O methyltransferase; Motor vehicle collision; Musculoskeletal pain; Stress

Indexed keywords

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; AGED; CATECHOL O-METHYLTRANSFERASE; CHRONIC PAIN; DISEASE SUSCEPTIBILITY; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUSCULOSKELETAL PAIN; PAIN MEASUREMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84894272698     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-013-8255-9     Document Type: Article

References (49)

1. Barbosa, F. R., Matsuda, J. B., Mazucato, M., de Castro Franca, S., Zingaretti, S. M., da Silva, L. M., et al. (2012). Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients. Rheumatology International, 32(2), 427-430.
2. Barnett, J. H., Heron, J., Goldman, D., Jones, P. B., & Xu, K. (2009). Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children. American Journal of Psychiatry, 166(8), 909-916.
3. Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005). Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics, 21(2), 263-265.
4. Bijur, P. E., Latimer, C. T., & Gallagher, E. J. (2003). Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Academic Emergency Medicine, 10(4), 390-392.
5. Bray, N. J., Buckland, P. R., Williams, N. M., Williams, H. J., Norton, N., Owen, M. J., et al. (2003). A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. American Journal of Human Genetics, 73(1), 152-161.
6. Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., et al. (2004). Functional analysis of genetic variation in catechol-O- methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics, 75(5), 807-821.
7. Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: Global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore, 23(2), 129-138.
8. Cohen, H., Neumann, L., Glazer, Y., Ebstein, R. P., & Buskila, D. (2009). The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia. Clinical and Experimental Rheumatology, 27(5 Suppl 56), S51-S56.
9. Diatchenko, L., Slade, G. D., Nackley, A. G., Bhalang, K., Sigurdsson, A., Belfer, I., et al. (2005). Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Human Molecular Genetics, 14(1), 135-143.
10. Diatchenko, L., Slade, G. D., Nackley, A. G., & Maixner, W. (2007). Responses to Drs. Kim and Dionne regarding comments on Diatchenko, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006; 125: 216-24. Pain, 129(3), 366-370.
11. Dworkin, R. H., Turk, D. C., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Katz, N. P., et al. (2005). Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain, 113(1-2), 9-19.
12. Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, B., et al. (2002). The structure of haplotype blocks in the human genome. Science, 296(5576), 2225-2229.
13. Gaysina, D., Xu, M. K., Barnett, J. H., Croudace, T. J., Wong, A., Richards, M., et al. (2013). The catechol-O-methyltransferase gene (COMT) and cognitive function from childhood through adolescence. Biological Psychology, 92(2), 359-364.
14. George, S. Z., Dover, G. C., Wallace, M. R., Sack, B. K., Herbstman, D. M., Aydog, E., et al. (2008a). Biopsychosocial influence on exercise-induced delayed onset muscle soreness at the shoulder: Pain catastrophizing and catechol-o-methyltransferase (COMT) diplotype predict pain ratings. Clinical Journal of Pain, 24(9), 793-801.
15. George, S. Z., Wallace, M. R., Wright, T. W., Moser, M. W., Greenfield, W. H, 3rd, Sack, B. K., et al. (2008b). Evidence for a biopsychosocial influence on shoulder pain: Pain catastrophizing and catechol-O-methyltransferase (COMT) diplotype predict clinical pain ratings. Pain, 136(1-2), 53-61.
16. Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., et al. (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences, 95(17), 9991-9996.
17. Gursoy, S., Erdal, E., Herken, H., Madenci, E., Alasehirli, B., & Erdal, N. (2003). Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatology International, 23(3), 104-107.
18. Hocking, L. J., Smith, B. H., Jones, G. T., Reid, D. M., Strachan, D. P., & Macfarlane, G. J. (2010). Genetic variation in the beta2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: Results from the 1958 British Birth Cohort Study. Pain, 149(1), 143-151.
19. Jacobsen, L. M., Schistad, E. I., Storesund, A., Pedersen, L. M., Rygh, L. J., Roe, C., et al. (2012). The COMT rs4680 Met allele contributes to long-lasting low back pain, sciatica and disability after lumbar disc herniation. European Journal of Pain, 16(7), 1064-1069.
20. Jiang, H., Xie, T., Ramsden, D. B., & Ho, S. L. (2003). Human catechol-O-methyltransferase down-regulation by estradiol. Neuropharmacology, 45(7), 1011-1018.
21. Katerberg, H., Cath, D. C., Denys, D. A., Heutink, P., Polman, A., van Nieuwerburgh, F. C., et al. (2010). The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B(1), 167-176.
22. Keller, S., Bann, C. M., Dodd, S. L., Schein, J., Mendoza, T. R., & Cleeland, C. S. (2004). Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clinical Journal of Pain, 20(5), 309-318.
23. Kraft, P., & Stram, D. O. (2007). Re: The use of inferred haplotypes in downstream analysis. American Journal of Human Genetics, 81(4), 863-865. author reply 865-866.
24. Lin, S., Cutler, D. J., Zwick, M. E., & Chakravarti, A. (2002). Haplotype inference in random population samples. American Journal of Human Genetics, 71(5), 1129-1137.
25. Lotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melen, K., Julkunen, I., et al. (1995). Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry, 34(13), 4202-4210.
26. Macrae, W. A., & Davies, D. H. O. (1999). Chronic post-surgical pain. In I. K. Crombie, P. Croft, M. Von Korff, & L. LeResche (Eds.), Epidemiology of pain (pp. 125-142). Seattle, WA: IASP Press.
27. Meyer-Lindenberg, A., Nichols, T., Callicott, J. H., Ding, J., Kolachana, B., Buckholtz, J., et al. (2006). Impact of complex genetic variation in COMT on human brain function. Molecular Psychiatry, 11(9), 867-877, 797.
28. Nackley, A. G., Shabalina, S. A., Tchivileva, I. E., Satterfield, K., Korchynskyi, O., Makarov, S. S., et al. (2006a). Human catechol-O- methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science, 314(5807), 1930-1933.
29. Nackley, A. G., Tan, K. S., Fecho, K., Flood, P., Diatchenko, L., & Maixner, W. (2006b). Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta(2)- and beta(3)-adrenergic receptors. Pain, 128(3), 199-208.
30. Nicholl, B. I., Holliday, K. L., Macfarlane, G. J., Thomson, W., Davies, K. A., O'Neill, T. W., et al. (2010). No evidence for a role of the catechol-O-methyltransferase pain sensitivity haplotypes in chronic widespread pain. Annals of the Rheumatic Diseases, 69(11), 2009-2012.
31. Paalzow, G. H., & Paalzow, L. K. (1983). Yohimbine both increases and decreases nociceptive thresholds in rats: Evaluation of the dose-response relationship. Naunyn-Schmiedeberg's Archives of Pharmacology, 322(3), 193-197.
32. Palmatier, M. A., Pakstis, A. J., Speed, W., Paschou, P., Goldman, D., Odunsi, A., et al. (2004). COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Molecular Psychiatry, 9(9), 859-870.
33. Pelissier, T., Laurido, C., Hernandez, A., Constandil, L., & Eschalier, A. (2006). Biphasic effect of apomorphine on rat nociception and effect of dopamine D2 receptor antagonists. European Journal of Pharmacology, 546(1-3), 40-47.
34. Platts-Mills, T. F., Ballina, L., Bortsov, A. V., Soward, A., Swor, R. A., Jones, J. S., et al. (2011). Using emergency department-based inception cohorts to determine genetic characteristics associated with long term patient outcomes after motor vehicle collision: Methodology of the CRASH study. BMC Emergency Medicine, 11, 14.
35. Pooley, E. C., Fineberg, N., & Harrison, P. J. (2007). The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: Case-control study and meta-analysis. Molecular Psychiatry, 12(6), 556-561.
36. Reuter, M., & Hennig, J. (2005). Association of the functional catechol-O-methyltransferase VAL158MET polymorphism with the personality trait of extraversion. NeuroReport, 16(10), 1135-1138.
37. Roth, J. A. (1992). Membrane-bound catechol-O-methyltransferase: A reevaluation of its role in the O-methylation of the catecholamine neurotransmitters. Reviews of Physiology Biochemistry and Pharmacology, 120, 1-29.
38. Shibata, K., Diatchenko, L., & Zaykin, D. V. (2009). Haplotype associations with quantitative traits in the presence of complex multilocus and heterogeneous effects. Genetic Epidemiology, 33(1), 63-78.
39. Shifman, S., Bronstein, M., Sternfeld, M., Pisante-Shalom, A., Lev-Lehman, E., Weizman, A., et al. (2002). A highly significant association between a COMT haplotype and schizophrenia. American Journal of Human Genetics, 71(6), 1296-1302.
40. Smith, S. B., Maixner, D. W., Greenspan, J. D., Dubner, R., Fillingim, R. B., Ohrbach, R., et al. (2011). Potential genetic risk factors for chronic TMD: Genetic associations from the OPPERA case control study. The Journal of Pain, 12(11 Suppl), T92-101.
41. Smolka, M. N., Buhler, M., Schumann, G., Klein, S., Hu, X. Z., Moayer, M., et al. (2007). Gene-gene effects on central processing of aversive stimuli. Molecular Psychiatry, 12(3), 307-317.
42. Talkowski, M. E., Kirov, G., Bamne, M., Georgieva, L., Torres, G., Mansour, H., et al. (2008). A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Human Molecular Genetics, 17(5), 747-758.
43. Tander, B., Gunes, S., Boke, O., Alayli, G., Kara, N., Bagci, H., et al. (2008). Polymorphisms of the serotonin-2A receptor and catechol-O- methyltransferase genes: A study on fibromyalgia susceptibility. Rheumatology International, 28(7), 685-691.
44. Tang, H., Quertermous, T., Rodriguez, B., Kardia, S. L., Zhu, X., Brown, A., et al. (2005). Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. American Journal of Human Genetics, 76(2), 268-275.
45. Tunbridge, E. M., & Harrison, P. J. (2011). Importance of the COMT gene for sex differences in brain function and predisposition to psychiatric disorders. Current Topics in Behavioral Neurosciences, 8, 119-140.
46. van Meurs, J. B., Uitterlinden, A. G., Stolk, L., Kerkhof, H. J., Hofman, A., Pols, H. A., et al. (2009). A functional polymorphism in the catechol-O-methyltransferase gene is associated with osteoarthritis-related pain. Arthritis and Rheumatism, 60(2), 628-629.
47. Vargas-Alarcon, G., Fragoso, J. M., Cruz-Robles, D., Vargas, A., Lao-Villadoniga, J. I., Garcia-Fructuoso, F., et al. (2007). Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther, 9(5), R110.
48. Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., et al. (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism, 33(2), 160-172.
49. Zubieta, J. K., Heitzeg, M. M., Smith, Y. R., Bueller, J. A., Xu, K., Xu, Y., et al. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science, 299(5610), 1240-1243. Diseases